Hong Kong Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

First Patient Dosed in Phase 3 Trial of Ivonescimab versus Tislelizumab for First-line Treatment of Squamous NSCLC
HONG KONG, Aug. 18, 2023. Akeso Inc. ( " Akeso " , 9926. HK) announced today that the first patient has been dosed in a head-to-head phase III trial of ivonescimab, a potential first-in-class investigational PD-1/VEGF bi-specific antibody discovered by... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - August 18, 2023 Category: Pharmaceuticals Source Type: clinical trials

Augmented Reality (AR) Hong Kong
Condition:   Educational Problems Intervention:   Other: Augmented Reality (AR) Sponsor:   Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2023 Category: Research Source Type: clinical trials